Valid Ghana · FDA Ghana

OMEGAMON​ ​CAPSULES

Docosahexaenoic acid/Eicosapentaenoic acid

FDA/SD.245-122342 Docosahexaenoic acid/Eicosapentaenoic acid 300mg/30mg

What it does

Docosahexaenoic is an omega-3 fatty acid that is beneficial for heart and brain health.

Commonly used for: high cholesterol (hyperlipidemia), heart disease (cardiovascular disease), inflammatory conditions, cognitive function support

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.245-122342
Registration date
2024-12-11
Expiry date
2030-01-01
Status
Valid
Active ingredient
Docosahexaenoic acid/Eicosapentaenoic acid
Strength
300mg/30mg
Pack size
-
Therapeutic class
-
RxNorm RxCUI
73
Manufacturer / MAH
Asoj Soft Caps
Country of origin
-

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:38 · updated 2026-10-20 04:00:08

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About docosahexaenoic

Docosahexaenoic is an omega-3 fatty acid that is beneficial for heart and brain health.

What it treats

  • high cholesterol (hyperlipidemia)
  • heart disease (cardiovascular disease)
  • inflammatory conditions
  • cognitive function support

How it works

It helps reduce inflammation and supports healthy brain and heart function.

Who it's for

It is suitable for adults looking to improve their heart and brain health, especially those with certain health conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About eicosapentaenoic

Eicosapentaenoic acid is a type of omega-3 fatty acid that supports heart health and reduces inflammation.

What it treats

  • high blood triglycerides (hypertriglyceridemia)
  • heart disease (cardiovascular disease)
  • inflammatory conditions

How it works

Eicosapentaenoic acid helps lower fat levels in the blood and can reduce swelling in the body.

Who it's for

It's suitable for people looking to improve heart health or manage high triglycerides.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: docosahexaenoic

Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is crucial for human health, particularly in the development and function of the brain, eyes, and cardiovascular system. It is predominantly found in fish oil and certain algae, and it plays an important role in cellular membrane fluidity and signaling pathways. DHA is often used as a dietary supplement to support cognitive function and cardiovascular health.

Indications

  • Support for cognitive function
  • Cardiovascular health
  • Anti-inflammatory effects
  • Eye health
  • Neuroprotection

Dosage

Children: Refer to specific product guidelines or clinical recommendations for dosage.

Adults: Refer to specific product guidelines or clinical recommendations for dosage.

Mechanism of action

DHA is incorporated into cell membranes, particularly in the brain and retina, where it contributes to membrane fluidity and function. It serves as a precursor for the synthesis of neuroprotective and anti-inflammatory mediators, including resolvins and protectins, which help to modulate inflammatory responses and promote neuronal health.

Pharmacodynamics

DHA influences various physiological processes, including lipid metabolism, inflammation, and neuronal signaling. It has been shown to enhance synaptic plasticity and cognitive functions, and it may exert cardioprotective effects by improving endothelial function and reducing triglyceride levels. DHA also plays a role in the modulation of gene expression related to inflammation and lipid metabolism.

Pharmacokinetics

DHA is absorbed from the gastrointestinal tract and distributed throughout the body, particularly to the brain and retina. Its bioavailability can be influenced by dietary factors and the presence of other fatty acids. Metabolism occurs primarily through beta-oxidation and incorporation into phospholipids, with elimination taking place via the bile and urine. The half-life of DHA varies, but its effects can be prolonged due to incorporation into tissue.

Adverse effects

  • Nausea
  • Diarrhea
  • Gastrointestinal discomfort
  • Increased bleeding tendency
  • Allergic reactions

Interactions

  • Anticoagulants (e.g., warfarin) - may increase the risk of bleeding
  • Antiplatelet drugs - may enhance the effects of these medications

Precautions

  • Use caution in patients with a known allergy to fish or shellfish
  • Monitor bleeding in patients taking anticoagulants or antiplatelet medications
  • Consult healthcare provider before use in patients with liver disease

Pregnancy

DHA is generally considered safe during pregnancy, but high doses should be avoided unless prescribed by a healthcare provider.

Breast-feeding

DHA is beneficial during breastfeeding, as it can support infant brain development, but consult a healthcare provider for dosage.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Softgel capsules
  • Liquid fish oil
  • Fortified foods and beverages

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: eicosapentaenoic

BNF-referenced

Eicosapentaenoic acid (EPA) is an omega-3 fatty acid that is primarily found in fish oils. It is known for its anti-inflammatory properties and its role in cardiovascular health. EPA is utilized as a dietary supplement and has been studied for its potential benefits in a variety of conditions, including hyperlipidemia, inflammatory diseases, and certain mental health disorders.

Indications

  • Hyperlipidemia
  • Cardiovascular disease prevention
  • Rheumatoid arthritis
  • Inflammatory bowel disease
  • Major depressive disorder

Dosage

Children: Refer to BNF for Children for specific dosing guidelines.

Adults: Refer to BNF for specific dosing guidelines, generally available in the form of supplements or prescription formulations.

Mechanism of action

Eicosapentaenoic acid works by influencing the production of eicosanoids, which are signaling molecules derived from fatty acids. It competes with arachidonic acid in the enzymatic pathways, leading to the production of less inflammatory eicosanoids. This shift in eicosanoid production is believed to contribute to reduced inflammation and improved cardiovascular outcomes.

Pharmacodynamics

The pharmacodynamic effects of EPA include the modulation of lipid levels, reduction of triglycerides, and anti-inflammatory effects. It has been shown to decrease platelet aggregation and may improve endothelial function, thus contributing to cardiovascular protection.

Pharmacokinetics

Eicosapentaenoic acid is readily absorbed from the gastrointestinal tract following oral administration. It undergoes metabolic processes in the liver and is incorporated into cell membranes, affecting cell signaling and inflammatory responses. The half-life of EPA is variable, influenced by dosage and individual metabolism, and it is primarily excreted in the urine and feces.

Adverse effects

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Flatulence
  • Rash

Precautions

  • Use with caution in patients with known hypersensitivity to fish or shellfish.
  • Monitor patients on anticoagulant therapy due to potential for increased bleeding risk.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Eicosapentaenoic acid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Eicosapentaenoic acid is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Capsules
  • Liquid formulations

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: eicosapentaenoic

PubChem CID 5282847

Molecular formula: C20H30O2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.